publication date: Dec. 19, 2010

In this issue: 

FDA approves Merck’s Gardasil vaccine to prevent cervical cancer.

FDA Roundup: Public Citizen uses logic of FDA’s Critical Path to challenge decision on anti-obesity drug.

Advocates oppose proposals to market drugs after phase I.

ODAC meets at ASCO, recommends approval of dasatinib for CML.

House subcommittee passes Bush request for NIH, NCI budgets.

NCI: The times have been “confusing,” Acting NCI Director Niederhuber admits in memo.

Download (PDF 938KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.